Baird Medical Investment Holdings (BDMD): Enterprise Value to EBITDA Ratio
This daily price action for the EV/EBITDA multiple of Baird Medical Investment (BDMD), whose metrics stand at 0.00, illustrates the impact of trade conflicts and US tariffs on the Chinese medtech vendor. Meanwhile, Baird Medical Investment (BDMD) maintains its status as an expert in minimally invasive tumor removal, earning widespread recognition from physicians. Positive momentum is supported by the company's expansion into the US market, driven by the safety of its methodologies.
Comprehensive metric breakdowns and analytics for Baird Medical Investment Holdings (BDMD)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
BDMD - Net Financial Result|Projected Future Earnings Baird Medical Investment|BDMD - Price to Earnings Ratio|Forward P/E Multiple Baird Medical Investment Holdings|BDMD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Baird Medical Investment|BDMD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Baird Medical|BDMD - Earnings per share for the trailing year|Quarterly EPS earnings growth bairdmed.com|BDMD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Baird Medical Investment
- sales volume and revenue indicators:
Analysis of all company metrics:Baird Medical Corp BDMD
The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit before interest, taxes, depreciation, and amortization, allowing for an objective asset valuation regardless of debt load. By analyzing the dynamic EV/EBITDA value of the company, an investor separates market volatility from fundamental value, which is critical for Baird Medical Investment (BDMD) given regional management risks and ambitious expansion plans into the US market.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple EDAP (EDAP TMS SA)|EV/EBITDA Multiple Apyx Medical APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (TELA Bio Corp) - Enterprise Value to EBITDA Ratio|CytoSorbents Corp - Business Value to Operating Income Before Depreciation|SRTS (Sensus) - EV/EBITDA Multiple|Company Value to EBITDA Zynex Medical ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
